Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus

Jang-Jih Lu; Shih-Yi Lee; Su-Yang Hwa; An-Hang Yang

首页> 外文期刊>Journal of Clinical Microbiology >Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus

【24h】

Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus

机译：万古霉素中间金黄色葡萄球菌引起的化脓性关节炎

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Four methicillin-resistant Staphylococcus aureus isolates were consecutively isolated from synovial fluid and a knee wound of a patient with septic arthritis. Determination of the MIC of vancomycin and population analysis confirmed these isolates as vancomycin-intermediate S. aureus (VISA). Results of this study also revealed that cell wall thickness and reduced susceptibility to Triton X-100 were characteristic features of VISA.

机译：从化脓性关节炎患者的滑液和膝部伤口中连续分离出四个耐甲氧西林的金黄色葡萄球菌菌株。万古霉素MIC的测定和群体分析证实了这些分离物为万古霉素中间体 S。金黄色（VISA）。这项研究的结果还表明，细胞壁厚度和对Triton X-100的敏感性降低是VISA的特征。 展开▼

著录项

来源
《Journal of Clinical Microbiology》 |2005年第8期|共3页

作者
Jang-Jih Lu; Shih-Yi Lee; Su-Yang Hwa; An-Hang Yang;
展开▼

作者单位

展开▼

收录信息

原文格式 PDF

正文语种

中图分类医学微生物学（病原细菌学、病原微生物学）;

关键词

相似文献

外文文献

中文文献

专利

1. Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin [J] . Lin Yu-Tzu, Tsai Jui-Chang, Yamamoto Tatsuo, The Journal of Antimicrobial Chemotherapy . 2016,第7期

机译：长期接受达托霉素治疗的化脓性关节炎患者中出现了万古霉素中间金黄色葡萄球菌的小菌落变体

2. Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis [J] . Wei-Yao Wang, Shih-Yi Lee, Tzong-Shi Chiueh, Journal of Clinical Microbiology . 2009,第11期

机译：败血症性关节炎患者耐甲氧西林和万古霉素金黄色葡萄球菌分离株的分子和表型特征

3. Left Ventricular Assist Device Endocarditis Caused by Vancomycin-Intermediate Staphylococcus aureus Successfully Treated with Ceftaroline: A Review of the Clinical Case and Overview of Vancomycin Resistance in Staphylococcus aureus [J] . Beydoun K., Wenzel R. Clinical Microbiology Newsletter . 2013,第21期

机译：头孢洛林成功治疗由万古霉素中间性金黄色葡萄球菌引起的左心室辅助装置心内膜炎：金黄色葡萄球菌对万古霉素耐药的临床病例和综述

4. Efficacy of Antibiotic Treatment and Vaccination on Subclinical Mastitis Caused by Staphylococcus aureus [C] . Eduardo de S. C. Pinheiro, Felipe Z. Freitas, Marcos V. dos Santos Annual Meeting of the National Mastitis Council . 2015

机译：抗生素治疗和疫苗接种对由金黄色葡萄球菌引起的亚临床乳腺炎的疗效

5. Development of Recombinant Staphylococcal Cytotoxins and Superantigens as Vaccine Candidates Against Bovine Mastitis Caused by Staphylococcus aureus [D] . Yoon, Sunghyun. 2019

机译：通过染色乳腺炎的疫苗候选疫苗患者的重组葡萄球菌细胞毒素和超剧性的发展

6. Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus [O] . Jang-Jih Lu, Shih-Yi Lee, Su-Yang Hwa, 2005

机译：万古霉素中间金黄色葡萄球菌引起的化脓性关节炎

7. Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus [O] . Lu, Jang-Jih, Lee, Shih-Yi, Hwa, Su-Yang, 2005

机译：万古霉素中间金黄色葡萄球菌引起的化脓性关节炎

8. Guideline for the Prevention and Management of Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE), and Vancomycin-Intermediate/Resistant Staphyloccocus aureus (VISA/VRSA) in Indiana Health Care [R] . 2004

机译：印第安纳州医疗保健中预防和管理耐甲氧西林金黄色葡萄球菌（mRsa），耐万古霉素肠球菌（VRE）和万古霉素中间/抗性金黄色葡萄球菌（VIsa / VRsa）的指南

1. 万古霉素单用及联合β内酰胺类药物治疗耐甲氧西林金黄色葡萄球菌引起的血流感染的效果观察 [J] . 陈雪莉 ,左维泽 ,陈光海 . 当代医药论丛 . 2015,第012期

2. 异质性万古霉素中介金黄色葡萄球菌的流行性及mgrA基因对万古霉素耐药性影响的研究 [J] . 刘彩林 ,明亮 . 中国抗生素杂志 . 2020,第002期

3. 万古霉素耐药折点调整对异质性万古霉素中介金黄色葡萄球菌筛选方法的影响 [J] . 刘明涛 ,李凯述 ,李超 . 中国感染与化疗杂志 . 2016,第004期

4. 万古霉素琼脂平板对异质性万古霉素中介金黄色葡萄球菌筛查价值的Meta分析 [J] . 蔡淑梅 ,朱海平 ,乔秀梅 . 中国抗生素杂志 . 2015,第003期

5. 万古霉素最低抑菌浓度与甲氧西林耐药金黄色葡萄球菌菌血症万古霉素治疗失败关系分析 [J] . Lodise TP ,Graves J ,Evans A . 中国感染与化疗杂志 . 2010,第002期

6. 1例脓毒症合并化脓性关节炎患儿万古霉素抗感染治疗病例分析 [C] . . 2017中国临床药学学术年会暨第十三届中国临床药师论坛 . 2017

7. 万古霉素对异质性万古霉素中介金黄色葡萄球菌生物膜构成的影响 [A] . 桑瑞瑞 . 2019

1. 一种对万古霉素耐药的耐甲氧西林金黄色葡萄球菌及应用 [P] . 中国专利： CN107435034B . 2020.10.20

2. 万古霉素结合牛血清白蛋白包被的磁珠分离金黄色葡萄球菌的新方法 [P] . 中国专利： CN106978412A . 2017-07-25

3. composition; pharmaceutical composition; combination therapy; medical apparatus; method for administering at least one glycylcycline and at least one heparin; method for the administration of glycylcycline and heparin; method of treating intraabdominal infections with complications (ciai) and cutaneous infections and complications of the cutaneous structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains and those resistant to staphylococcus aureus ( mssa and mrsa); method of treating intraabdominal infections with complications (ciai) and infections of the cutaneous and complicating skin structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains of staphylococcus aureus ( mssa and mrsa) in a patient in need; antibiotic administration method; article of manufacture; kit; use of a glycylcillin of formula I or a pharmaceutically acceptable salt thereof; use of a heparin or pha [P] . 外国专利： BRPI0611070A2 . 2010-08-03

机译：组成;药物组合物;联合疗法医疗器械至少一种缩水甘油环素和至少一种肝素的给药方法;甘氨酰环素和肝素的给药方法;治疗由革兰氏阴性和革兰氏阳性病原体，厌氧和耐甲氧西林的菌株以及对金黄色葡萄球菌有抵抗力的菌株（mssa和mrsa）引起的合并症（ciai）和腹腔内感染的并发症（ciai）和皮肤感染以及皮肤结构并发症（csssi）;革兰氏阴性和革兰氏阳性病原体，金黄色葡萄球菌厌氧和耐甲氧西林菌株（mssa和mrsa）引起的并发症（CIAI）和皮肤感染和皮肤复杂结构（CSSS）感染的腹腔内感染的治疗方法;抗生素给药方法;制品;套件式I的糖基西林或其药学上可接受的盐的用途;肝素或相的使用

4. Genetic marker and method for detection of heterogenous vancomycin-intermediate Staphylococcus aureus using graS gene variation [P] . 外国专利： KR101390256B1 . 2014-05-29

机译：利用graS基因变异检测万古霉素中间金黄色葡萄球菌的遗传标记和方法

5. GENETIC MARKER AND METHOD FOR DETECTION OF HETEROGENOUS VANCOMYCIN-INTERMEDIATE STAPHYLOCOCCUS AUREUS USING GRAS GENE VARIATION [P] . 外国专利： KR20130120638A . 2013-11-05

机译：利用GRAS基因变异检测万古霉素中间金黄色葡萄球菌的遗传标记和方法

相关主题

Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus

摘要

著录项

相似文献

相关主题

期刊订阅